María Paquita García

María Paquita García

Auto-generated profile, based on publicly available information

María Paquita García

National Reference Laboratory for Vector-borne and Viral Zoonotic Diseases, National Institute of Health, Lima, Peru

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2022 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
MGM. Paquita Garcia
M. Paquita Garcia
CPCarlos Padilla-Rojas
Carlos Padilla-Rojas
DFDana Figueroa
Dana Figueroa
CMCarlos Manrique
Carlos Manrique
CCCesar Cabezas
Cesar Cabezas
Emergencia del genotipo Cosmopolitan del virus dengue serotipo 2 (DENV2) en Madre de Dios, Perú, 2019

4 December 2024 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
HCHenri Bailon Calderon
Henri Bailon Calderon
VVVICTOR ALBERTO JIMENEZ VASQUEZ
VICTOR ALBERTO JIMENEZ VASQUEZ
MGMarco Antonio Galarza-Pérez
Marco Antonio Galarza-Pérez
PMPrincesa Medrano
Princesa Medrano
OMOrson Mestanza
Orson Mestanza
MGMaría P. García
María P. García
Objectives. This study aimed to evaluate the prevalence and distribution of dengue virus genotype V serotype 1 (DENV-1) and cosmopolitan genotype serotype 2 (DENV-2) in Peru between 2019 and 2022. Materials and methods. The envelope (E) gene region was amplified from 79 serum samples by polymerase chain reaction (PCR) and sequenced by next-generation sequencing (NGS) technology. The obtained sequences were subsequently analyzed with bioinformatics tools. Results. The study generated envelope gene sequences of DENV-1 and DENV-2 serotypes. Our study revealed a rapid dispersal and wide distribution of the cosmopolitan DENV-2 genotype in several regions of Peru in 2022, as well as the spread of DENV-1 genotype V to new Peruvian regions, along with the cosmopolitan DENV-2 genotype. Conclusions. Our findings suggest the urgent need to strengthen epidemiological and genomic surveillance systems to understand and control the spread of circulating DENV genotypes in Peru. This will allow a more rapid response, as well as the monitoring of its potential dissemination to other countries in the Americas.

1 September 2012 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
WMWilfredo Martin Casapia Morales
Wilfredo Martin Casapia Morales
EMEnrique Mamani
Enrique Mamani
MGMaría P García
María P García
MMMaría L Miraval
María L Miraval
PVPedro Valencia
Pedro Valencia
LDLuis F Donaires
Luis F Donaires
Hantavirus infection is a viral zoonotic infection borne by rodents which most letal form clinical is the Hantavirus Pulmonary Syndrome (SPH, Spanish abbreviation). The Mamore River variant originates in South America and was found in rodents without any association to human diseases. Two cases of SPH were identified in the Peruvian Amazon region in November 2011. In both cases, a molecular diagnostic testing was conducted by the Instituto Nacional de Salud from Peru. A phylogenetic analysis of a viral genome fragment and a histopathological evaluation were conducted. Both patients developed adult respiratory distress syndrome and refractory shock. A patient died and another one recovered 12 days later.

6 May 2016 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Closed access
MGMaría P. García
María P. García
NMNancy S. Merino
Nancy S. Merino
DFDana Figueroa
Dana Figueroa
AMAdolfo Marcelo
Adolfo Marcelo
EVEdwin Tineo V.
Edwin Tineo V.
CCCésar Cabezas
César Cabezas

1 March 2010 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
EMEnrique Mamani
Enrique Mamani
DFDana Figueroa
Dana Figueroa
MGMaría Paquita García
María Paquita García
MGMaría del Carmen Garaycochea
María del Carmen Garaycochea
EPEdwar J. Pozo
Edwar J. Pozo
To establish the existence of concurrent infections by different dengue virus (DENV) serotypes in an outbreak in the Northwestern in Peru during 2008. 73 serum samples from patients with dengue were analyzed during an outbreak that occurred in Northwestern in Peru between May and June 2008. Molecular biology techniques were used to serotype the DENV, thus, firstly the viral RNA viral was extracted using Viral QIAamp RNA mini kit (Qiagen, Valencia, California, USA), then the viral cDNA fragments were reverse transcripted and amplified by means of the Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and the RT-Nested PCR region techniques and finally, genetic sequencing of the viral cDNA fragments were performed using the Big Dye Terminator v.3,1 kit. The 73 dengue cases presented infections by different serotypes: 34 (46.6%) by DENV-3, 29 (39.7%) by DENV-1, 4 (5.5%) by DENV-4, and 6 (8.2%) concurrent infections by DENV-1 and DENV-3. The most frequent clinical manifestations observed among dengue patients were fever and headache (100%), myalgia (94.5%), ocular pain (83.6%), arthralgia (78.1%), shivers (63.0%), nausea/vomiting (38.4%), positive tourniquet test (30.1%), and rash (20.5%). All patients with concurrent infections presented light clinical course of dengue fever (DF) except one patient who had moderate hemorrhagic manifestations. This is the first Peruvian report of patients with concurrent infections of two DENV serotypes without severe clinical manifestations.

21 August 2020 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
PPPaul Pachas
Paul Pachas
FDFernando Donaires
Fernando Donaires
RGRonnie G. Gavilán
Ronnie G. Gavilán
WQWilli Quino
Willi Quino
MVMargot Vidal
Margot Vidal
LSLely Solari
Lely Solari
Objetivo: Describir los resultados de los exámenes de laboratorio realizados en muestras biológicas de pacientescon síndrome de Guillain-Barré (SGB), recibidas en el Instituto Nacional de Salud (INS) entre los años 2018y 2019. Materiales y métodos: Se realizó un estudio observacional en pacientes con SGB notificados en elsistema de vigilancia epidemiológica. Se obtuvieron muestras biológicas analizadas en el INS para investigararbovirus, virus respiratorios, enterovirus y enterobacterias, entre otros. Resultados: Se recibió un total de2051 especímenes clínicos de 906 pacientes con SGB. Tres pacientes dieron positivo al dengue y tres pacientesal Zika. En 19 pacientes, el cultivo en heces fue positivo para Campylobacter jejuni. El análisis filogenético dediez cepas de Campylobacter jejuni las clasificó como genotipo ST2993, reportado previamente en China yasociado a un brote de SGB. En 2018, hubo 12 muestras que habían dado positivo al PCR para enterovirus enel líquido cefalorraquídeo, pero ninguna pudo corroborarse con el cultivo respectivo ni con secuenciamientode genoma completo. Un paciente dio positivo por virus de la influenza A, dos por virus de la influenza B, dospor adenovirus, cinco por virus respiratorio sincicial, y diez por rinovirus. Conclusión: Se han encontradodiversos agentes patógenos en especímenes de pacientes con SGB, sin embargo, la presencia de Campylobacterjejuni genotipo ST2993, un patógeno relacionado a brotes de SGB en varios continentes, sería el probable agentecausal. Es necesario confirmar esta hipótesis con estudios analíticos y determinar la cadena de transmisión deeste agente para implementar las medidas de prevención y control.